title: Efficacy and safety of atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorder.
abstract: Several non-stimulant medications have been used in the treatment of attention deficit hyperactivity disorder (ADHD). Atomoxetine, was introduced in 2002. The safety and efficacy of atomoxetine in the treatment of ADHD for children, adolescents, and adults has been evaluated in over 4000 patients in randomized controlled studies and double blinded studies as well as in recent large longitudinal studies. This paper provides an updated summary of the literature on atomoxetine, particularly in relation to findings on the short- and long-term safety of atomoxetine in children and adolescents arising from recent large longitudinal cohort studies. Information is presented about the efficacy, safety, and tolerability of this medication.
authors: Centre for Research into Adolescents' Health (CRASH), The Sydney Children's Hospital Network and Westmead Hospital, Westmead, NSW, Australia.
authors: Michael R
authors: MR
authors: Kohn
authors: Tracey W
authors: TW
authors: Tsang
authors: Simon D
authors: SD
authors: Clarke
keywords: ADHD; adolescents; atomoxetine; children; efficacy; safety
references: Pediatrics. 2011 Apr;127(4):e862-8
references: 21422081
references: J Paediatr Child Health. 2010 Jan;46(1-2):66
references: 20412195
references: J Child Adolesc Psychopharmacol. 2009 Oct;19(5):547-51
references: 19877979
references: J Am Acad Child Adolesc Psychiatry. 1996 Nov;35(11):1460-9
references: 8936912
references: Curr Drug Saf. 2008 May;3(2):123-31
references: 18690990
references: Clin Toxicol (Phila). 2007;45(2):182-5
references: 17364639
references: J Am Acad Child Adolesc Psychiatry. 2006 Nov;45(11):1304-1313
references: 17023868
references: J Atten Disord. 2004 Oct;8(2):45-52
references: 15801334
references: Neuropharmacology. 2006 May;50(6):755-60
references: 16427661
references: Psychiatry Investig. 2011 Jun;8(2):141-8
references: 21852991
references: J Pharmacol Exp Ther. 1982 Jul;222(1):61-5
references: 6123593
references: Neuropsychiatr Dis Treat. 2009;5:215-26
references: 19557116
references: J Paediatr Child Health. 2008 Oct;44(10):596-8
references: 19012633
references: J Child Adolesc Psychopharmacol. 2011 Feb;21(1):21-32
references: 21288121
references: J Child Adolesc Psychopharmacol. 2009 Oct;19(5):485-92
references: 19877972
references: J Emerg Med. 2006 Oct;31(3):267-8
references: 16982359
references: Clin Pharmacol Ther. 2003 Mar;73(3):178-91
references: 12621383
references: Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27;37(1):81-9
references: 22227291
references: Curr Med Res Opin. 2009 Nov;25(11):2745-54
references: 19785510
references: Am J Psychiatry. 2009 Sep;166(9):992-1001
references: 19528194
references: J Child Adolesc Psychopharmacol. 2009 Aug;19(4):341-50
references: 19702486
references: J Child Adolesc Psychopharmacol. 2009 Apr;19(2):155-66
references: 19364293
references: Pediatrics. 2008 Aug;122(2):451-3
references: 18676566
references: Arch Gen Psychiatry. 2004 Jul;61(7):731-6
references: 15237085
references: J Am Acad Child Adolesc Psychiatry. 2010 Jun;49(6):573-82
references: 20494267
references: J Child Adolesc Psychopharmacol. 2007 Oct;17(5):689-700
references: 17979588
references: J Child Adolesc Psychopharmacol. 2009 Dec;19(6):709-18
references: 20035589
references: J Child Adolesc Psychopharmacol. 2009 Dec;19(6):699-707
references: 20035588
references: J Am Acad Child Adolesc Psychiatry. 2006 Aug;45(8):919-927
references: 16865034
references: Neuropsychopharmacology. 2002 Nov;27(5):699-711
references: 12431845
references: Int J Neuropsychopharmacol. 2010 Mar;13(2):243-56
references: 19849892
references: J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):1015-1027
references: 17667480
references: Int J Psychiatry Clin Pract. 2011 Jun;15(2):145-56
references: 22121863
references: Curr Med Res Opin. 2010 Sep;26(9):2087-95
references: 20642391
references: Am J Psychiatry. 2008 Jun;165(6):721-30
references: 18281409
references: J Atten Disord. 2008 Nov;12(3):248-53
references: 18448861
references: Ann Pharmacother. 2005 Jun;39(6):1045-8
references: 15870137
references: J Pediatr. 2006 Jul;149(1):112-9
references: 16860138
references: Dev Med Child Neurol. 2007 Jul;49(7):498-502
references: 17593120
references: Br J Pharmacol. 2009 Jan;156(2):226-36
references: 19154426
references: Eur Neuropsychopharmacol. 2009 Nov;19(11):822-34
references: 19716683
references: J Child Adolesc Psychopharmacol. 2009 Dec;19(6):719-30
references: 20035590
references: Eur Child Adolesc Psychiatry. 2010 Jan;19(1):57-66
references: 19568826
references: Clin Toxicol (Phila). 2006;44(3):243-7
references: 16749540
references: Int J Neuropsychopharmacol. 2012 Feb;15(1):15-26
references: 22017969
references: J Emerg Med. 2007 Feb;32(2):175-8
references: 17307628
references: Child Adolesc Psychiatry Ment Health. 2008 Sep 15;2(1):25
references: 18793405
references: J Child Adolesc Psychopharmacol. 2011 Oct;21(5):433-44
references: 22040189
references: J Clin Psychiatry. 2010 Nov;71(11):1535-51
references: 20673557
references: Qual Life Res. 2011 Jun;20(5):691-702
references: 21136299
references: J Clin Psychopharmacol. 2009 Oct;29(5):453-60
references: 19745645
references: Eur Child Adolesc Psychiatry. 2009 Apr;18(4):240-9
references: 19156355
references: J Child Adolesc Psychopharmacol. 2009 Jun;19(3):253-63
references: 19519260
references: J Child Adolesc Psychopharmacol. 2011 Apr;21(2):97-110
references: 21488751
references: J Am Acad Child Adolesc Psychiatry. 2011 Jan;50(1):73-84.e1
references: 21156272
references: Eur Child Adolesc Psychiatry. 2009 Aug;18(8):493-8
references: 19377865
references: J Atten Disord. 2013 Aug;17(6):497-505
references: 22366240
references: Child Adolesc Psychiatry Ment Health. 2009 Aug 24;3(1):21
references: 19703299
references: J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):894-921
references: 17581453
references: Drug Saf. 2009;32(11):1089-96
references: 19810780
references: Circulation. 2008 May 6;117(18):2407-23
references: 18427125
references: J Clin Psychiatry. 2007 Apr;68(4):582-7
references: 17474814
references: J Child Adolesc Psychopharmacol. 2006 Oct;16(5):611-9
references: 17069549
references: Psychopharmacology (Berl). 2007 Oct;194(2):197-209
references: 17572882
references: J Pediatr. 2006 Jun;148(6):831-4
references: 16769398
references: Pediatrics. 2005 Jul;116(1):e74-80
references: 15995021
references: Sleep. 2006 Dec;29(12):1573-85
references: 17252888
references: Eur Child Adolesc Psychiatry. 2011 Jan;20(1):17-37
references: 21042924
references: JAMA. 2011 Dec 28;306(24):2673-83
references: 22161946
references: Curr Neuropharmacol. 2008 Dec;6(4):322-8
references: 19587853
references: Am J Psychiatry. 2002 Nov;159(11):1896-901
references: 12411225
references: Clin Pharmacokinet. 2005;44(6):571-90
references: 15910008
references: Child Adolesc Psychiatry Ment Health. 2009 Dec 15;3:40
references: 20003507
references: J Child Adolesc Psychopharmacol. 2009 Oct;19(5):493-9
references: 19877973
references: Psychiatr Q. 2011 Dec;82(4):303-8
references: 21437723
references: J Child Neurol. 2011 Jan;26(1):31-6
references: 20525942
references: Child Psychiatry Hum Dev. 2011 Jun;42(3):257-69
references: 21165694
references: Drug Saf. 2008;31(4):345-54
references: 18366245
references: J Am Acad Child Adolesc Psychiatry. 2009 Feb;48(2):176-85
references: 20040824
references: Int J Psychiatry Med. 2007;37(4):415-24
references: 18441629
references: J Am Acad Child Adolesc Psychiatry. 2007 May;46(5):566-572
references: 17450047